Ischemic preconditioning suppresses ventricular tachyarrhythmias after myocardial revascularization

Zhong-Kai Wu1, Tiina Iivainen, Erkki Pehkonen

  • 1Division of Cardiac Surgery, Department of Surgery, Tampere University Hospital, Tampere, Finland.

Circulation
|December 11, 2002
PubMed

Insights

Ischemic preconditioning (IP) effectively reduces life-threatening ventricular fibrillation (VF) and tachycardia (VT) after coronary artery bypass grafting (CABG). This study demonstrates IP

Area of Science:

  • Cardiovascular Surgery
  • Cardiac Electrophysiology
  • Ischemic Preconditioning

Background:

  • Ventricular fibrillation (VF) and ventricular tachycardia (VT) are critical complications post-coronary artery bypass grafting (CABG).
  • Ischemic preconditioning (IP) is known to reduce ischemia-reperfusion arrhythmias in experimental and human studies.
  • The efficacy of IP in preventing postoperative VF/VT in CABG patients remained uninvestigated.

Purpose of the Study:

  • To evaluate the effectiveness of ischemic preconditioning (IP) in suppressing ventricular fibrillation (VF) and ventricular tachycardia (VT) in patients undergoing coronary artery bypass grafting (CABG).
  • To assess the impact of IP on the duration and frequency of VF/VT episodes post-CABG.
  • To determine if IP influences mechanical ventilation duration and inotrope requirements after CABG.

Main Methods:

  • Eighty-six patients with 3-vessel disease undergoing CABG were randomized into an IP group or a control group.
  • The IP group received two cycles of 2-minute ischemia followed by 3-minute reperfusion before the main procedure.
  • Twenty-four-hour electrocardiographic monitoring was performed, and clinical outcomes were recorded.

Main Results:

  • IP significantly reduced the incidence of VF after declamping (48.8% vs. 79.1%, P=0.004) and shortened the VF duration (2.28 min vs. 4.41 min, P=0.002).
  • Episodes of VT were significantly decreased in the IP group during early and 24-hour reperfusion (P=0.000 and P=0.002, respectively).
  • No de novo sustained VT occurred in the IP group post-surgery, compared to 3 control patients; IP also reduced ventilation time and inotrope use.

Conclusions:

  • Ischemic preconditioning (IP) demonstrates significant efficacy in reducing postoperative ventricular fibrillation/tachycardia (VF/VT) in CABG patients with 3-vessel disease.
  • The suppression of VT during early and delayed reperfusion phases suggests both immediate and sustained protective effects of IP.
  • IP may offer a protective strategy against arrhythmias and improve recovery outcomes in patients undergoing CABG surgery.
Abstract